Feature Channels: Vaccines

• share
• favorite_border

Federal officials are describing a ‘tripledemic’ of respiratory infections on the rise. Flu, COVID-19, and RSV are spiking, as expected, as we are in the mid-winter months. Lisa M. Lee, a professor of public health at Virginia Tech, answered questions about factors for concern and the importance of vaccination. Lee is an epidemiologist and bioethicist who has worked in public health and ethics for 25 years, including 14 years with CDC.

• share
• favorite_border

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.

• share
• favorite_border

Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.

• share
• favorite_border

A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase

• share
• favorite_border

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

• share
• favorite_border

As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.

• share
• favorite_border

Find the latest research and features on fertility in the Fertility News Source on Newswise.

• share
• favorite_border

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

• share
• favorite_border

A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.

• share
• favorite_border

Study examines the impact of flu, RSV and COVID-19 hitting pediatric emergency departments

• share
• favorite_border

• share
• favorite_border

A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.In a new paper in the journal Acta Biomaterialia, Professor William Murphy and collaborators in his lab detail how using an optimized mineral coating composition can maintain mRNA activity for up to six months at room temperature.

• share
• favorite_border

New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.

• share
• favorite_border

Expert on melanoma cancer vaccine currently in clinical trials, and showing promise